First Drug To Delay Type 1 Diabetes Gets UK Approval, Offers New Hope

Summary

The United Kingdom has approved the use of teplizumab, a drug that can delay the onset of Type 1 diabetes, offering new hope for individuals with the condition. This medication works by altering the immune system to protect the cells in the pancreas that produce insulin, and it has been shown to postpone the development of symptomatic Type 1 diabetes by nearly three years. Teplizumab is now available for adults and children with stage 2 Type 1 diabetes who are eight years of age or older, and it is given intravenously once a day for fourteen days.